Inhaled Drug Development
Product Description
QUOTIENT SCIENCES LIMITED
-
GB -
2017On CPHI since
-
500 - 999Employees
Company types
Categories
Specifications
QUOTIENT SCIENCES LIMITED
-
GB
-
2017On CPHI since
-
500 - 999Employees
Company types
More Products from QUOTIENT SCIENCES LIMITED (16)
-
Product Bioanaysis
Delivering rapid bioanalytical data in discovery – preclinical – clinical. Bioanalysis is a critical step in the drug development process. At Quotient, we are experts in the development, validation, and application of bioanalytical assays.
Our dedicated team of bioanalytical chemists... -
Product Data Sciences
You need data rapidly to make crucial decisions during a study. Faster data means we can provide our customers with earlier interim data and interim PK reports for on-study dosing and formulation decisions.
We understand on-study changes to early phase study designs and d... -
Product Drug Development Consulting
Our Drug Development Consultants work with you to design and implement successful drug development programs. With industry leading scientific expertise across a range of technical disciplines, we help customers across all stages of development, from candidate selection to commercial launch.
Our cons... -
Product Global Clinical Trial Supply
Accelerate your timeline, with flexible, on-demand delivery. We’ll design and develop your packaging, labelling and distribution strategy for Phase I, Phase II and Phase III clinical studies, so you’ll no longer have to worry about the challenge of getting your drug product to multiple sites in time fo... -
Product Pediatric Development
Pediatric formulation and product development
The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements. Quotient Sciences has extensive knowledge and capabilities that enable us to provide you... -
Product Orphan Drug Development
Accelerating orphan drug development from candidate selection to commercial manufacture and supply.
With over 300 million people worldwide living with identified rare diseases, the development of new treatments to address these unmet clinical needs is an area of great interest in the pha... -
Product Translational Pharmaceutics - Integrated Programs
Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs. qq... -
Product Oncology
Supporting oncology drug development from candidate selection through to commercial manufacture and supply
In the past 5 years alone, Quotient has successfully worked on over 300 oncology development projects for 91 different oncology drug candidates spanning 34 different disea... -
Product Candidate Selection - Integrated Programs
Selecting the right molecules for development - Quickly identify the best drug candidates. Knowing what it takes to develop a successful drug, we help clients select the best molecules for development. Our unique integration of scientific capabilities enables us to provide a complete assessment o... -
Product Early Stage Development - Integrated Programs
Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabil... -
Product Late Stage Development - Integrated Programs
.Accelerating products through to commercial manufacture - Speed the journey from proof-of-concept to commercial launch. The journey from proof-of-concept to commercial launch can be complex. Speed is critical but it shouldn’t come at the expense of product quality. Creating patient-centric formulatio... -
Product Drug Substance
Our streamlined approach to developing drug substance has been shown to reduce manufacturing costs by 50% from preclinical to Phase I. To best support our customer’s needs, we have made significant investments in technologies and equipment to meet the increasing demand for complex small-scale dr...
QUOTIENT SCIENCES LIMITED resources (2)
-
News Quotient Sciences acquires UK-based CDMO Arcinova
With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide -
Technical Data Formulation Development at Quotient
Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance